1. Home
  2. SON vs IRTC Comparison

SON vs IRTC Comparison

Compare SON & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$56.43

Market Cap

4.7B

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$114.92

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
IRTC
Founded
1899
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.8B
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
SON
IRTC
Price
$56.43
$114.92
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$62.50
$200.23
AVG Volume (30 Days)
748.5K
461.7K
Earning Date
04-21-2026
04-30-2026
Dividend Yield
3.78%
N/A
EPS Growth
510.30
61.71
EPS
10.07
N/A
Revenue
$7,518,753,000.00
$747,138,000.00
Revenue This Year
$0.03
$19.60
Revenue Next Year
$2.01
$15.94
P/E Ratio
$5.57
N/A
Revenue Growth
41.72
26.24
52 Week Low
$38.65
$97.16
52 Week High
$58.44
$210.01

Technical Indicators

Market Signals
Indicator
SON
IRTC
Relative Strength Index (RSI) 65.88 38.37
Support Level $44.59 $112.65
Resistance Level $58.44 $124.40
Average True Range (ATR) 1.13 4.67
MACD 0.30 1.06
Stochastic Oscillator 91.36 16.60

Price Performance

Historical Comparison
SON
IRTC

About SON Sonoco Products Company

Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: